ArticleAntimicrobial agents and chemotherapy1999

Therapeutic effects of benzoxazinorifamycin KRM-1648 administered alone or in combination with a half-sized secretory leukocyte protease inhibitor or the nonsteroidal anti-inflammatory drug diclofenac sodium against Mycobacterium avium complex infection in mice.

C Sano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.